Profound Medical Announces U.S. FDA 510(k) Clearance for TULSA-PRO®
Profound Medical announced that they have received 510(k) clearance from the U.S. Food and Drug Administration to market TULSA-PRO® for ablation of prostate tissue.
Previous
Previous
iMerciv Accepted into CTA Silicon Valley Fall 2019 Cohort
Next
Next